Charles River Laboratories (CRL) Misses Q1 EPS by 2c; Reaffirms Outlook

May 1, 2013 4:53 PM

Charles River Laboratories (NYSE: CRL) reported Q1 EPS of $0.69, $0.02 worse than the analyst estimate of ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found